Literature DB >> 2460880

Induction of angiogenic response by chemically stable prostacyclin analogs.

A Ohtsu1, K Fujii, S Kurozumi.   

Abstract

Angiogenic activities of several chemically stable prostacyclin analogs (isocarbacyclins and 7-fluoro prostacyclin) were evaluated by the chick embryo chorioallantoic membrane assay. These compounds showed potent angiogenic activity at very low concentration (0.1 micrograms/egg 1.0 micrograms/egg), whereas naturally occurring prostaglandins such as prostacyclin and PGE1 were almost ineffective up to 1 microgram/egg. Pretreatment of chorioallantoic membranes with dexamethasone or indomethacin inhibited the angiogenic response induced by these chemically stable prostacyclin analogs. These results indicate that these prostacyclin analogs induce the angiogenic response of chick chorioallantoic membranes via a mechanism involving activation of inflammatory cells, as well as through their direct angiogenic activity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2460880     DOI: 10.1016/0952-3278(88)90120-2

Source DB:  PubMed          Journal:  Prostaglandins Leukot Essent Fatty Acids        ISSN: 0952-3278            Impact factor:   4.006


  4 in total

1.  Effects of isocarbacyclin, a stable prostacyclin analogue, on monkey isolated cerebral and peripheral arteries.

Authors:  Y Kawai; T Ohhashi
Journal:  Br J Pharmacol       Date:  1994-06       Impact factor: 8.739

2.  Eicosapentaenoic acid inhibits tube formation of vascular endothelial cells in vitro.

Authors:  T Kanayasu; I Morita; J Nakao-Hayashi; N Asuwa; C Fujisawa; T Ishii; H Ito; S Murota
Journal:  Lipids       Date:  1991-04       Impact factor: 1.880

3.  Coordinated regulation of vascular endothelial cell growth and prostacyclin production by epidermal growth factor: evidence of clonal variations among rat aortic endothelial cells.

Authors:  J K Chen; Y T Lau; J Chu
Journal:  In Vitro Cell Dev Biol       Date:  1992-02

Review 4.  Tumour vasculature--a potential therapeutic target.

Authors:  C T Baillie; M C Winslet; N J Bradley
Journal:  Br J Cancer       Date:  1995-08       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.